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Abstract
Background: The increasing adoption of hospital electronic prescribing and medication administration (ePA)
systems has driven a wealth of research around the impact on patient safety. Yet relatively little research has sought
to understand the effects on staff, particularly pharmacists. We aimed to investigate the effects of ePA on
pharmacists’ activities, including interactions with patients and health professionals, and their perceptions of
medication safety risks.
Methods: A mixed methods study comprising quantitative direct observations of ward pharmacists before and
after implementation of ePA in an English hospital, and semi-structured interviews post-ePA. Quantitative data
comprised multi-dimensional work activity sampling to establish the proportion of time ward pharmacists spent on
different tasks, with whom and where. These data were extrapolated to estimate task duration. Qualitative
interviews with pharmacists explored perceived impact on (i) ward activities, (ii) interactions with patients and
different health professionals, (iii) locations where tasks were carried out, and (iv) medication errors.
Results: Observations totalled 116 h and 50 min. Task duration analysis suggested screening inpatient medication
increased by 16 mins per 10 patients reviewed (p = 0.002), and searching for paper drug charts or computer
decreased by 2 mins per 10 patients reviewed (p = 0.001). Pharmacists mainly worked alone (58% of time pre- and
65% post-ePA, p = 0.17), with patient interactions reducing from 5 to 2% of time (p = 0.03). Seven main themes
were identified from the interviews, underpinned by a core explanatory concept around the enhanced and shifting
role of the ward pharmacist post-ePA. Pharmacists perceived there to be a number of valuable safety features with
ePA. However, paradoxically, some of these may have also inadvertently contributed to medication errors.
Conclusion: This study provides quantitative and qualitative insights into the effects of implementing ePA on ward
pharmacists’ activities. Some tasks took longer while others reduced, and pharmacists may spend less time with
patients with ePA. Pharmacists valued a number of safety features associated with ePA but also perceived an overall
increase in medication risk. Pharmacy staff demonstrated a degree of resilience to ensure ‘business as usual’ by
enhancing and adapting their role.
Keywords: Electronic prescribing, Electronic prescribing and medication administration system, Computerised
physician order entry (CPOE), Pharmacist, Patient safety, Medication safety, Mixed methods, Work-sampling,
Workflow, Interview
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Background
The uptake of hospital inpatient electronic prescribing
and medication administration (ePA) systems is increas-
ing, with benefits cited as reduced adverse drug events,
medication errors, length of stay, and healthcare costs,
and more accurate communication among healthcare
professionals [1–5]. However, other evidence challenges
the extent of such benefits [6, 7]. The adoption of a
complex intervention such as ePA will bring about con-
siderable organizational change, especially in the daily
work of frontline staff [8–10]. Not surprisingly, there are
cases of unsuccessful ePA implementations with the
main reason cited as users’ resistance [11, 12]. However,
relatively little research has focused on the impact of
ePA on the people and processes required to realise the
improvements in patient care.
In England, pharmacists provide an important
ward-based clinical service to inpatients and support to
ward staff [13]. The three English studies in this area
provide a mixed picture of the impact of ePA on ward
pharmacists. Some suggest pharmacists spend less time
with patients [7, 14] and doctors post-ePA [7, 15], and
require increased time for ward activities [7, 15]. An-
other suggests no change in time with patients [15] and
a reduction in time on specific tasks such as ordering
medications, searching for drug charts and checking pa-
tients’ own drugs [15]. An Australian study suggests
pharmacists spend less time with patients as drug charts
were no longer at their bedside, more time working
alone, were interrupted less often and spent less time
reviewing medications [16]. However, these studies were
conducted some time ago in hospitals where ePA was
implemented on few wards, and mobile computing de-
vices were not always available or were too cumbersome
to use at patients’ bedsides. Hospital-wide ePA may have
a different impact on pharmacists’ activities and medica-
tion safety, as suggested by more recent US studies [17,
18]. Understanding the wider effects in an English hos-
pital setting is particularly pertinent as significant Na-
tional Health Service (NHS) funds are being used to
incentivise greater uptake of ePA [19]. Greater under-
standing is also essential to aid workforce planning and
to influence staff acceptance and use of ePA to improve
patient safety. The aim of this study was to investigate
the impact of implementing a hospital-wide ePA system
on ward pharmacists’ activities, including their interac-
tions with patients and health professionals, and their
perceptions of medication safety risks.
Methods
Study design
This was an uncontrolled before-and-after study using
an explanatory sequential mixed methods design [20].
This design enables quantitative results to be explained
using qualitative methods and was chosen to provide
greater understanding of the effects of ePA on ward
pharmacy practice. Quantitative activity sampling of
ward pharmacists’ work before and after implementation
of a hospital-wide ePA system was therefore followed by
semi-structured qualitative interviews.
Setting
We studied an acute admissions ward and a
medicine-for-the-elderly ward in a large English NHS
teaching hospital. These wards were purposively chosen
to represent differences in patient length of stay, ward
staff working practices, and pharmacy services. Typical
UK hospital ward pharmacist activities were carried out
on both wards, including taking medication histories,
reconciling medications on admission, reviewing medi-
cation orders for clinical appropriateness, ordering med-
ications, reviewing medications for discharge, patient
counselling and some ward-based dispensing. On the
acute admissions ward, pharmacy staff carried out these
activities seven days a week as part of a ward-based ser-
vice. This also included attendance at each of the two
consultant-led ward rounds Mondays to Fridays, and
one each Saturday and Sunday. In contrast, on the
medicine-for-the-elderly ward, a single pharmacist pro-
vided a two hour ward visit Monday to Friday and
attended one consultant-led ward round each week. The
ePA system, a component of a commercial electronic
health record system already in use at the hospital, was
implemented on both study wards in March 2016 as part
of the second phase of hospital-wide roll-out. Clinical
decision support within the ePA system mainly com-
prised tools such documentation templates,
condition-specific order sets, and medication-specific re-
view reminders. Drug allergy alerts were in operation,
but other computerised alerts such as drug-drug interac-
tions were not activated. There was no formal change in
ward pharmacy resources provided post-ePA.
Recruitment and consent
All eight pharmacists covering both study wards were
invited to participate in the observations and interviews.
Those willing to take part provided written consent and
mutually convenient time(s) and day(s) for observations
and interviews were agreed.
Quantitative work activity sampling
Direct observations of pharmacists’ ward visits were
planned for every 3–4 weekdays on each ward between
January 2016 (approximately 1.5 months pre-ePA) and
June 2016 (3months post-ePA). One observation session
typically lasted around two hours. Observations were
scheduled to take place at two different times (after the
morning ward round and late afternoon) on the acute
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admissions ward to capture potential variation in
ward-based activities as it was impractical to observe the
pharmacist for their entire eight-hour shift. As pharma-
cists on the medicine-for-the-elderly ward were not
ward-based all day, observations were scheduled in the
morning for the duration of their ward visit and they were
asked to document any ward-related activities undertaken
outside the ward visit using pre-piloted data collection
forms on the days observed. Additionally, the presence of
any other pharmacy staff on the ward was recorded.
A standard random interval three-dimensional work
sampling approach [21] was used by LH to collect data on
(i) different types of tasks carried out, (ii) with whom, and
(iii) where. Briefly, a random signal generator (JD-7, Divil-
bliss Electronics, Champaign, Illinois) was set to produce
32 silent vibration alerts (‘activity samples’) per hour with
random intervals between successive alerts. The researcher
recorded data on pre-piloted forms each time an alert was
produced e.g. a two-hour observation would be expected to
generate 64 alerts and therefore 64 activity samples would
be documented. This can be used to provide an estimate of
the proportion of overall time spent on the different tasks
[22]. The same researcher (LH) collected data both pre-
and post-ePA and carried out a series of pilot observations
on the study wards to become familiar with the data collec-
tion tool, and to allow ward staff to become familiar with
being observed, before starting data collection. An existing
task list [23] was expanded from 11 to 20 tasks (Add-
itional file 1) by further subdividing existing categories to
provide greater granularity and facilitate identification of
task changes that were potentially more ePA-specific. Each
task was also assigned by one researcher (MM) as being ei-
ther value-added or non-value-added from a patient’s per-
spective, based on Lean methodology, to facilitate
identification of potentially ‘wasteful’ or non-value-added
steps [24]. This classification was verified separately by a
second member of the research team (BDF). Contextual
data such as pharmacists’ post-qualification years of experi-
ence, number of patients reviewed, and observation start
and stop times were also recorded.
Qualitative semi-structured interviews
One-to-one semi-structured interviews were carried out by
GK in May 2016 (approximately seven weeks post-ePA)
using a pre-piloted topic guide Additional file 2. Pharmacists
were asked questions around their perceptions of the impact
of ePA on (i) their ward activities, (ii) interactions with pa-
tients and different health professionals, (iii) locations where
tasks were carried out, and (iv) medication errors. Interviews
were audio recorded and transcribed verbatim.
Data analysis
Quantitative analysis focused on the change in estimated
time spent on value-added and non-value-added tasks
on both wards. Estimates of time were based on ten pa-
tients reviewed to provide context with respect to impli-
cations for pharmacy services and to take into account
any changes in numbers of patients reviewed. The per-
centage of time spent on each task overall was also cal-
culated to provide an overview of how pharmacists
spent their time. As this was an exploratory study, an a
priori sample size was not calculated. We used the Bon-
ferroni correction for multiple testing and adopted a
p-value of 0.0028 for assessing whether differences in
task duration were statistically significant. We also com-
pared median time per patient reviewed. Mann-Whitney
U tests (for non-parametric data) and unpaired t-tests
(for parametric data), with a two-tailed significance of
0.05, were used to explore potential differences between
mean percentage of time spent on different tasks per ob-
servation, and mean percentage of time per observation
with patients, different health professionals, and loca-
tions where tasks were carried out pre- and post-ePA.
Qualitative data were analysed using a deductive the-
matic approach with initial themes generated based on
study objectives [25]. One researcher (GK) reviewed all
interview recordings and transcripts to maximise famil-
iarity with the data prior to coding and adjusted the cod-
ing frame accordingly. Each transcript was coded
manually on paper. A second researcher (MM) reviewed
the coding and identified high level themes that were
later refined with the rest of the research team before
being finalised.
Findings from the quantitative and qualitative data ana-
lyses were compared to explore areas of agreement and dis-
agreement between measured and perceived impact of ePA
on pharmacists’ activities. The modified Good Reporting of
Mixed Methods Study guideline for pharmacy practice was
used to support transparent reporting [26].
Results
Seven of the eight pharmacists were observed, over a total
of 116 h and 50min (Table 1). The median time per patient
reviewed was 17min pre- and 22min post-ePA; the differ-
ence was not statistically significant (p = 0.16). Six of the
seven pharmacists covered both the admissions and
medicine-for-the-elderly wards during the observation
period; these six pharmacists also participated in the inter-
views (experience 1.5 to 6.5 years). Additional pharmacy
support from at least one other team member was available
for some or all of the time observed on the acute admis-
sions ward (84% of 44 observations) and were mainly pro-
vided by a pharmacy technician (73% of observations). An
additional pharmacist was available pre- (39% of observa-
tions) and post-ePA (62% of observations), and
pre-registration trainee support (pre-ePA 28% and post-ePA
0% of observations) on the acute admissions ward. Add-
itional ward-related activities carried outside of the ward
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visit by pharmacists on the medicine-for-the-elderly ward
were reported for only one day pre-ePA and three days
post-ePA; these data were therefore excluded from analysis.
Quantitative work sampling
Overall task analysis indicates that pharmacists spent most
time on: professional communication (relating to patient
care but unrelated to medication, 15.9% of time pre-ePA
and 15.1% post-ePA, p = 0.62); screening inpatient medica-
tion (11.6% pre- and 17.4% post-ePA, p = 0.20); and screen-
ing discharge medication (11.0% pre- and 6.2% post-ePA,
p = 0.45) Additional file 3. There was no statistically signifi-
cant difference in the percentage of time spent on any of
the individual tasks pre- and post-ePA except for taking a
drug history (6.5% pre- and 13.2% post-ePA, p = 0.02).
Duration of value-added and non-value-added tasks
There was no statistically significant difference in the
total time spent on all tasks combined (value-added and
non-value-added) per 10 patients reviewed post-ePA
(Fig. 1). Only two specific tasks were associated with a
significant change post-ePA: screening inpatient medica-
tion increased by 16 mins per 10 patients reviewed (p =
0.002), and searching for drug charts decreased by 2
mins per 10 patients reviewed (p = 0.001).
Interactions with patients/visitors and other health care
professionals
Pharmacists spent the majority of their time working
solo (Fig. 2) both pre- and post-ePA (60 and 65% of time
respectively, with the difference not statistically signifi-
cant). However, the percentage of time spent interacting
with patients and/or their visitors was significantly less
post-ePA (p = 0.03). Interactions with “other persons” in-
cluded: ward clerk, occupational therapist, researcher,
and information technology support staff.
Locations of work on the ward
On the acute admissions ward, pharmacists spent the
majority of time observed working in the ward office,
which changed little post-ePA (Fig. 3A). In comparison,
pharmacists on the medicine-for-the-elderly ward ap-
peared to shift from working in the corridor (where
health records trolley and paper drug charts were some-
times located) to the nurses’ station (Fig. 3B); however,
there was no statistically significant difference pre- and
post-ePA. ‘Other’ locations for both wards were: medica-
tion storage room, patient bay (but not at bedside), visit-
ing room, toilet, kitchen, and stairs.
Interview findings
Overall, we identified seven main themes from the inter-
view transcripts: (i) more efficient and effective screening of
medications post-ePA, (ii) more time-consuming daily
work, (iii) fewer patient interactions and a less natural com-
munication mode, (iv) more interactions with other health
professionals but less face-to-face communication, (v) dis-
cussions with other health professionals and patients are
more focused on problem solving, (vi) patients valued over
medical records as a reliable source of medication history,
and (vii) higher prevalence of medication errors. These
were interlinked by a core concept: the enhanced and shift-
ing role of the ward pharmacist post-ePA. We present this
concept below as the primary finding from integration of
quantitative and qualitative data. Selected verbatim quotes
are included for illustrative purposes.
The enhanced and shifting role of pharmacists post-ePA
A principal aspect of a ward pharmacist’s responsibilities
is to clinically screen patients’ medications, ensuring ac-
curacy as well as appropriateness and practicality for
use. While this remains the case, interviews with phar-
macists post-ePA suggest that they were also taking on
more of a transcribing role by ordering medication based
on a doctor’s verbal request plus an ePA support role for
Table 1 Overview of observations
Acute admissions Medicine for the Elderly Both wards combined
Pre-ePA Post-ePA p-value Pre-ePA Post-ePA p-value Pre-ePA Post-ePA p-value
Number of observations 18 26 – 6 13 – 24 39 –
Total observation time (h:min) 33:21 47:42 – 10:09 25:38 – 43:30 73:20 –
Mean duration of
observation (h:min)
1:51
(SD 14 mins)
1:50
(SD 14 mins)
0.80 1:42
(SD 28 mins)
1:58
(SD 16 mins)
0.11 1:49
(SD 18 mins)
1:53
(SD 15 mins)
0.34
Median number of patients
reviewed per observation
6
(range 2–10)
5
(range 1–16)
0.18 18
(range 3–22)
9
(range 3–22)
0.48 6
(range 2–22)
5
(range 1–22)
0.36
Number of activity samples 990 1424 – 297 752 – 1287 2176 –
Median time per patient
reviewed (mins, 95% CI)
19
(15–24)
21
(20–30)
0.14 7
(4–22)
14 (5–24) 0.20 17
(15–22)
22 (17–24) 0.16
Abbreviations: CI confidence interval, ePA electronic prescribing and medication administration system, SD standard deviation
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Fig. 2 Estimated percentage of time observed working alone or interacting with others by pharmacist. Estimations were based on 1346 activity
samples pre-electronic prescribing and administration (ePA) and 2176 post-ePA. Total exceeds 100% as pharmacists sometimes interacted with
more than one other individual. * denotes p-value <0.05 (unpaired t-test)
Fig. 1 Estimated mean change in time per 10 patients reviewed by pharmacist post electronic prescribing and administration (ePA). *statistical
significance based on Bonferroni p-value <0.0028 (unpaired t-test). ‘Other’: casual conversation, scheduled break, waiting for equipment to
become available, researcher-related activity, searching for equipment, auditing, handwashing, and unknown tasks
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ward staff in general. Pharmacists reported being
approached by doctors and other ward staff more fre-
quently to make prescription changes on the ePA sys-
tem, for advice on how to use the ePA system, and for
troubleshooting.
“Our role has changed a lot more to be a person who
updates the actual drug chart and updates the actual
prescriptions. Because it is a new system the junior
doctors, I think rely a lot more heavily on the fact that
we can PC [amend on behalf of a “prescriber
contacted”] amendments or changes, or additions.
………. now just on ward round alone, the drug chart
screen is only really looked at by us [pharmacists]”.
(Pharmacist 1; 4 years’ experience)
“Yeah, technical issues, …….. definitely I’ve got more
questions from nurses about what things mean on [the
A
B
Fig. 3 Estimated percentage of time observed working in different locations by pharmacist: (a) acute admissions, (b) medicine-for-the-elderly
ward. Abbreviation: ePA, electronic prescribing and administration
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ePA system], or can I help them find something. Or if
they’ve signed for something accidentally, how do they
reverse it and things like that. And then from a
doctors’ point of view, I suppose just feeding back
things that they can do differently”. (Pharmacist 2; 1.5
years’ experience)
Despite their greater transcribing and additional tech-
nical support roles, pharmacists themselves strived to
continue to provide a ‘typical’ clinical pharmacy service
and recognised many advantages and disadvantages of
ePA. Pharmacists believed that the ePA system enabled
more efficient screening of drug charts and a greater
propensity to make meaningful clinical contributions for
optimising a patient’s medications. Specific features of
the ePA system, including a pharmacy medicines man-
agement page, were highlighted as helpful for prioritising
patients at each visit. However, pharmacists perceived
some common routine tasks, such as taking a medica-
tion history, to be more time-consuming.
“….there’s a vast amount of information available now
when I’m seeing those patients for a first time on ward
round ….. that wasn’t available to me pre [ePA] …
[the ePA system] allows everything to kind of be
gathered into one… I find myself being able to screen a
drug chart clinically with a lot more information on a
ward round” (Pharmacist 1, 4 years’ experience)
“The time I think I spend putting information into [the
ePA system] takes a lot longer post implementation. It
takes a lot longer for me to do a drug history, do a
meds rec’ [medicines reconciliation] and finish [with] a
patient before I’m happy to move onto another one”.
(Pharmacist 1, 4 years’ experience)
Pharmacists who believed ePA facilitated clinical
screening attributed this to having more convenient
access to patient records that allowed them to review
medications, laboratory results and medical notes
concurrently. However, paradoxically, this meant
pharmacists would sometimes spend more time
reviewing a patient’s medications as they were review-
ing the medical notes and laboratory results more fre-
quently. Given that pharmacists reported little change
in the way they prioritised their ward activities (i.e.
reviewing new patients and those due to be dis-
charged first), the consequence was that pharmacists
carried out fewer patient reviews post-ePA for those
who were not new or due to be discharged. This per-
ceived reduction in the number of patients reviewed
was further compounded by a lack of computer ter-
minals, which was often reported as a rate-limiting
step. One pharmacist mentioned the introduction of
‘computer ownership’ on the wards, whereby groups
of staff would designate computers for their own use.
“So I think first of all trying to get a computer is an
issue. I work on one particular ward and they’ve
basically put stickers on a lot of their computers-on-
wheels saying ‘This is for nurses’ use’, which is really
difficult for you as a pharmacist [……] you end up go-
ing and writing it all down on paper and then going
back to a computer and sitting down and putting it all
onto [the ePA system] and that’s really time consuming
because you’re duplicating the work ….” (Pharmacist 4;
6.5 years’ experience)
An important unintended consequence of ePA was
that pharmacists perceived they were interacting with
fewer patients, and that although the conversations held
were more targeted (e.g. focused around a specific ques-
tion), they were of a less natural mode.
“I definitely think it [the ePA system] cuts down on
patient interaction … So, yeah, unfortunately I think it
definitely cuts down on patient interactions and
meaningful patient interactions … Previously you
would have been seeing everyone on a daily basis at
their bedside but now if you can’t find a computer you
don’t do that and more commonly the purpose for
going is to get the drug history or to ask questions
rather than going along on a day to day basis and
checking in with the patient”. (Pharmacist 4; 6.5 years’
experience)
“Taking a device to the bedside still kind of takes away
a little bit from a natural conversation because of the
inputting you’re doing at the same time as having a
conversation with someone[…….] And I feel like with a
chart pre [ePA] implementation, the conversation was
a little bit more natural”. (Pharmacist 1; 4 years’
experience)
Perceived impact of ePA on patient safety
A prevalent belief was that ePA had increased the preva-
lence of medication errors (both minor and severe).
Pharmacists also reported on examples of medication
risks with ePA as compared with paper drug charts.
Interview findings suggests the perceived increase in
medication errors may be due to six types of situation:
(i) ePA nudges users to do the ‘wrong’ thing, (ii) ePA in-
discriminately defaults to specific actions, (iii) ePA
makes error less visible compared to paper drug chart,
(iv) ePA makes error more visible compared to paper
drug chart, (v) ePA makes other key information less vis-
ible, and (vi) ePA clinical decision support does not meet
McLeod et al. BMC Health Services Research          (2019) 19:156 Page 7 of 12
Ta
b
le
2
El
ec
tr
on
ic
pr
es
cr
ib
in
g
an
d
m
ed
ic
at
io
n
ad
m
in
ist
ra
tio
n
(e
PA
)f
ea
tu
re
s
th
at
co
nt
rib
ut
ed
to
pe
rc
ep
tio
n
of
in
cr
ea
se
d
m
ed
ic
at
io
n
ris
k
eP
A
fe
at
ur
es
Im
pl
ic
at
io
ns
fo
r
pr
ac
tic
e
Ex
am
pl
es
fro
m
ph
ar
m
ac
is
t
in
te
rv
ie
w
s
1.
Sy
st
em
nu
dg
es
us
er
s
to
do
th
e
‘w
ro
ng
’t
hi
ng
Th
es
e
ar
e
ris
ks
th
at
co
ul
d
be
re
du
ce
d
w
ith
sy
st
em
im
pr
ov
em
en
ts
an
d/
or
be
tt
er
us
er
tr
ai
ni
ng
“S
o
th
e
do
ct
or
s
w
ill
of
te
n
ju
st
cl
ic
k
w
hi
ch
ev
er
on
e
[in
su
lin
]
is
fir
st
,w
hi
ch
is
of
te
n,
sa
y,
a
ca
rt
rid
ge
of
on
e
an
d
th
e
pa
tie
nt
’s
go
t
a
Fl
ex
Pe
n
an
d
it’
s
th
e
pe
n
th
at
’s
be
in
g
us
ed
”
(P
ha
rm
ac
is
t
3;
2.
9
ye
ar
s’
ex
pe
rie
nc
e)
2.
Sy
st
em
in
di
sc
rim
in
at
el
y
de
fa
ul
ts
to
sp
ec
ifi
c
ac
tio
ns
“L
ik
e
th
e
do
ct
or
s
sa
yi
ng
th
ey
’v
e
pr
es
cr
ib
ed
an
tib
io
tic
s,
bu
t
if
it’
s
pa
st
a
ce
rt
ai
n
tim
ef
ra
m
e
it’
ll
au
to
m
at
ic
al
ly
lik
e
se
t
th
e
ne
xt
tim
e.
If
yo
u
pr
es
cr
ib
ed
it
at
lik
e
10
am
an
d
it
is
tw
ic
e
a
da
y,
it’
ll
se
t
to
10
pm
an
d
th
ey
do
n’
t
al
w
ay
s
re
m
em
be
r
to
pu
t
lik
e
a
st
at
[o
nc
e
on
ly
]
do
se
to
be
gi
ve
n
st
ra
ig
ht
aw
ay
”
(P
ha
rm
ac
is
t
3;
2.
9
ye
ar
s’
ex
pe
rie
nc
e)
3.
Sy
st
em
m
ak
es
er
ro
r
le
ss
vi
si
bl
e
(t
ha
n
a
pa
pe
r
dr
ug
ch
ar
t)
“I
se
e
a
lo
t
m
or
e
du
pl
ic
at
io
n
of
pr
es
cr
ip
tio
ns
th
an
Id
id
on
pa
pe
r
dr
ug
ch
ar
ts
.I
th
in
k
th
at
do
ct
or
s
ar
e
no
t
ne
ce
ss
ar
ily
lo
ok
in
g
at
th
e
dr
ug
ch
ar
t
pr
op
er
ly
in
th
e
sa
m
e
w
ay
th
at
yo
u
m
ig
ht
w
ith
a
pa
pe
r
dr
ug
ch
ar
t.
D
up
lic
at
io
n
is
so
m
et
hi
ng
Is
ee
da
y
in
,d
ay
ou
t;
th
ey
’re
as
ke
d
to
pr
es
cr
ib
e
so
m
et
hi
ng
an
d
th
ey
do
n’
t
se
em
to
re
al
ise
th
e
pa
tie
nt
’s
al
re
ad
y
on
it”
.
(P
ha
rm
ac
is
t
4,
6.
5
ye
ar
s’
ex
pe
rie
nc
e)
“S
o
m
iss
ed
do
se
s
so
m
et
im
es
It
hi
nk
[o
n
eP
A]
ar
en
’t
as
ap
pa
re
nt
or
th
er
e
is
a
w
ay
th
at
th
ey
ca
n
dr
op
of
f…
It
hi
nk
it
[m
iss
ed
do
se
s]
w
as
m
or
e
ap
pa
re
nt
on
a
pa
pe
r
ch
ar
t
…
So
th
er
e
ar
e
w
ay
s
w
he
re
yo
u
vi
ew
th
e
dr
ug
ch
ar
ts
fo
r
a
tim
e
pe
rio
d
an
d
yo
u
ha
ve
to
ha
ve
yo
ur
op
tio
ns
an
d
yo
ur
se
tt
in
gs
…
Yo
ur
de
fa
ul
t
se
tt
in
g
at
w
ha
t
yo
u
lo
ok
at
ha
s
to
be
lik
e
bi
g
en
ou
gh
or
co
ve
r
a
tim
e
pe
rio
d
th
at
is
bi
g
en
ou
gh
to
sh
ow
yo
u
th
in
gs
lik
e
th
at
do
se
w
as
m
iss
ed
ye
st
er
da
y.
Be
ca
us
e
if
yo
u’
re
ju
st
lo
ok
in
g
at
to
da
y’s
dr
ug
ad
m
in
ist
ra
tio
n
th
en
yo
u
w
on
’t
se
e
th
at
.S
o
th
at
’s
ki
nd
of
th
e
sy
st
em
ha
s
cr
ea
te
d
th
at
.W
he
re
as
on
a
pa
pe
r
ch
ar
t
yo
u
w
ou
ld
se
e
ki
nd
of
th
e
pr
es
cr
ip
tio
n
an
d
it
w
ou
ld
sh
ow
yo
u
al
lt
he
da
ys
fo
r
th
at
14
da
ys
”.
(P
ha
rm
ac
ist
1,
4
ye
ar
s’
ex
pe
rie
nc
e)
4.
Sy
st
em
m
ak
es
er
ro
r
m
or
e
vi
si
bl
e
(t
ha
n
a
pa
pe
r
dr
ug
ch
ar
t)
Th
is
is
a
sa
fe
ty
fe
at
ur
e
th
at
ra
is
es
aw
ar
en
es
s
of
an
er
ro
r
“I
th
in
k
m
iss
ed
do
se
s
ar
e
m
or
e
ob
vi
ou
s
no
w
.O
bv
io
us
ly
on
pa
pe
r
yo
u
di
dn
’t
ha
ve
th
is
co
ns
ta
nt
re
m
in
de
r,
w
he
re
as
on
[th
e
eP
A
sy
st
em
]
no
w
,a
fte
r
an
ho
ur
ha
s
el
ap
se
d
fro
m
th
e
tim
e
it
w
as
du
e,
th
e
bo
x
go
es
re
d,
th
e
ad
m
in
ist
ra
tio
n
bo
x
go
es
re
d.
”
(P
ha
rm
ac
is
t
2;
1.
5
ye
ar
s’
ex
pe
rie
nc
e)
5.
eP
A
m
ak
es
ot
he
r
ke
y
in
fo
rm
at
io
n
le
ss
vi
si
bl
e
(c
om
pa
re
d
to
pa
pe
r
dr
ug
ch
ar
ts
)
Th
is
is
a
ris
k
th
at
co
ul
d
be
re
du
ce
d
w
ith
sy
st
em
im
pr
ov
em
en
ts
an
d/
or
be
tt
er
us
er
tr
ai
ni
ng
“T
he
re
’s
al
so
an
no
ta
tin
g
so
m
e
of
th
e
pr
es
cr
ip
tio
ns
as
w
el
lf
or
lik
e
th
er
ap
eu
tic
dr
ug
m
on
ito
rin
g,
w
hi
ch
is
pr
ob
ab
ly
a
do
w
ns
id
e
to
[th
e
eP
A
sy
st
em
]
in
so
m
e
re
sp
ec
ts
in
th
at
pr
ev
io
us
ly
,f
or
ex
am
pl
e,
am
in
og
ly
co
sid
es
,y
ou
w
ou
ld
w
rit
e
...
ge
nt
am
ic
in
,t
he
le
ve
ll
es
s
th
an
1,
[th
en
]
yo
u’
d
pu
t
a
bo
x
as
to
w
he
n
th
ey
ne
ed
to
ta
ke
th
e
le
ve
l,
yo
u
co
ul
d
te
ll
th
em
to
ta
ke
th
e
le
ve
lt
he
n
gi
ve
or
ta
ke
th
e
le
ve
lt
he
n
ho
ld
;y
ou
do
n’
t
ha
ve
th
e
op
po
rt
un
ity
to
do
th
at
on
th
e
dr
ug
ch
ar
t
or
on
th
e
ad
m
in
ist
ra
tio
n
ch
ar
t
on
th
e
el
ec
tr
on
ic
pr
es
cr
ib
in
g
th
e
w
ay
yo
u
co
ul
d
on
a
pa
pe
r
dr
ug
ch
ar
t”
.(
Ph
ar
m
ac
is
t
4;
6.
5
ye
ar
s’
ex
pe
rie
nc
e)
6.
Sy
st
em
cl
in
ic
al
de
ci
si
on
su
pp
or
t
no
t
m
ee
tin
g
us
er
s’
ex
pe
ct
at
io
ns
Th
is
is
a
ris
k
th
at
co
ul
d
be
re
du
ce
d
w
ith
be
tt
er
us
er
tr
ai
ni
ng
“D
oc
to
rs
…
th
ey
pr
es
cr
ib
e
so
m
et
hi
ng
af
te
r
8
am
an
d
it
do
es
n’
t
fla
g
th
en
as
be
in
g
du
e
un
til
th
e
ne
xt
da
y.
”
(P
ha
rm
ac
is
t
2;
1.
5
ye
ar
s’
ex
pe
rie
nc
e)
McLeod et al. BMC Health Services Research          (2019) 19:156 Page 8 of 12
users’ expectations. Examples are provided in Table 2.
Five were risks that could be reduced by improving user
training. Of these, four could be reduced with system
improvement. The remaining factor was not a medica-
tion risk but a safety feature that raises awareness that
an error has occurred, in that omitted doses were per-
ceived to be more visible with ePA.
Pharmacists also reported a number of ePA-based pa-
tient safety improvements e.g. every prescription is al-
ways clear and complete with medication order details,
name and bleep number of the prescriber. This facili-
tates investigation of medication errors as well as feed-
back to those involved. The ePA system also prevents
medications from being prescribed if there is a docu-
mented allergy to the drug concerned in the patient’s
record. However, pharmacists believed that it was hu-
man safety nets, namely doctors, nurses and pharmacists
looking at medication orders, which allowed errors to be
rectified before they can cause severe harm.
“I'd like to think that, because there are lots of
different teams looking at the prescriptions, not just
one person, that errors will be identified, similar to if
they were written incorrectly. So I don't think it’s any
more or less dangerous than a paper chart…”
(Pharmacist 6, 5 years’ experience)
Discussion
Key findings
This study has revealed a number of effects of imple-
menting ePA on ward pharmacists’ activities. Some rou-
tine tasks took longer while others reduced post-ePA,
which corroborates previous research [15, 16]. Pharma-
cists perceived a reduction in time spent with patients
and visitors, which was supported by the small but sta-
tistically significant reduction identified from our quanti-
tative results. However, there was neither a change in
the overall time spent at patients’ bedside, nor a signifi-
cant increase in time spent in the ward office or nurses’
station where a large number of computers were located,
a finding that was not anticipated. Pharmacists valued a
number of safety features associated with ePA but also
perceived an overall increase in medication risk. We at-
tributed this to six types of situations. The majority
could be improved with enhanced user training but four
would also benefit from system redesign.
Interpretation
Our findings suggest a key underlying change post-ePA
was the enhanced and shifting role of the ward pharma-
cist. Pharmacists generally perceived an enhanced ability
to review patients’ medications more comprehensively
and efficiently (despite perceiving some tasks to take
longer), a greater transcribing role in ordering new med-
ications on behalf of some doctors and that they were
seen as an ePA expert among ward staff.
The enhanced pharmacists’ role may be associated
with the perceived increase in the number of medication
errors from a more thorough medication review, and the
increase in time spent reviewing inpatient medications.
Previous studies suggest a mixed picture of positive and
negative impact of ePA on patient safety with respect to
medication use [7, 14]. Our study builds on these find-
ings by identifying six types of situations that are poten-
tially linked to ePA, and which increased the perception
of error (Table 2). In considering these factors and in the
context of implementation, our findings suggest the per-
ceived impact of ePA may also be attributed to any re-
cent experience of using paper drug charts by
pharmacists and other ward staff. Specifically, ‘ePA
makes error less visible compared to paper drug chart’,
‘ePA makes error more visible compared to paper drug
chart’, and ‘ePA makes other key information less visible’.
The apparent contradiction of the same ePA feature
making an error less or more visible by different phar-
macists may be influenced by the time period for which
the drug administration record was being viewed. Unlike
previous paper drug charts which allowed users to rec-
ord and view drug administrations for up to 14 days, the
ePA records all drug administrations for the whole dur-
ation of the inpatient stay but only a small number fit
into a single screen for viewing at any one time. Users
can scroll backwards and forwards in time to view other
drug administrations. This suggests any actions taken to
address this perceived risk should consider the contexts
in which the ePA feature can be used. There appears to
be an implicit expectation from pharmacists that ePA
would provide the ‘same functionalities and more’ than a
paper drug chart. However, in practice, paper drug
charts afforded users a degree of flexibility where they
were able to annotate as necessary. Thus paper drug
charts were being routinely adapted to communicate an
array of information at a glance that was no longer as
visible using ePA. For example, pharmacists reported
not being able to annotate a box with ePA to indicate
when the next gentamicin level was due (Table 2) - this
communication was routinely used by pharmacists to
provide drug monitoring advice and a reminder for ac-
tion to be taken by ward staff.
With respect to the ‘ePA expert’ role, interviewed
pharmacists perceived that others expect them to have
greater knowledge of how to use the ePA system. In
practice, pharmacy staff at the study site received the
same level and quantity of training (adapted for
role-specific tasks) as doctors and other ward staff.
Given that ePA was implemented relatively recently in
our study, it is possible that the pharmacist’s role is still
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changing. The additional ePA expert role may dissipate
as greater ePA knowledge and experience becomes em-
bedded among core staff across all disciplines.
Patients play an important role in medication safety
and can contribute to reducing medication error
when health professionals involve patients in their
care [27, 28]. A common concern among pharmacists
was the perceived reduction in patient contact time,
which resonates with findings from a previous study
with medical staff [14]. Similar to an earlier English
study [15], our study suggests that the nature of in-
teractions with patients changed from having more
routine and opportunistic discussions to more tar-
geted discussion around specific medications, particu-
larly on the acute admissions ward. This may explain
why the overall time spent with patients changed lit-
tle post-ePA i.e. fewer patients were seen but they
were seen for longer periods of time post-epA. While
the clinical significance of reduced patient contact is
unclear, pharmacist interviews suggest that patients
are still viewed as an integral part of the medication
review process.
Strengths and limitations
A strength of this study was the use of a planned ex-
planatory mixed methods approach. This not only
allowed us to triangulate our findings but also
allowed us to gain a more in-depth understanding of
contributing factors for post-ePA effects observed. In
particular, the same pharmacists participated in both
the quantitative and qualitative parts of the study,
which ensured interviews were of maximum relevance
to the observational data collected. Furthermore, there
was a high level of engagement and involvement from
pharmacy staff at multiple stages of the research (in-
cluding study design, pilot work, data analysis and
write-up).
Limitations include lack of data on tasks carried out
by pharmacists outside of the ward visit, not observing
the acute admissions pharmacist for the whole day, a
small sample of observations, data being collected start-
ing immediately post-implementation which will there-
fore include any ‘settling in’ time, the presence of an
observer potentially affecting the way the pharmacists
worked, and lack of data on the tasks carried out by
other pharmacy staff who were supporting the observed
pharmacists. Our study was also conducted at one hos-
pital and therefore may not be generalizable to other set-
tings. Finally, we used a relatively large number of
different task types, compared to other studies, that pro-
vided us with greater granularity of potential specific ef-
fects of ePA, but it also reduced the statistical power for
detecting differences.
Implications for practice
It was recognised within the pharmacy department con-
cerned that revision to existing guidance on clinical
ward service provision was needed to better support in-
dividuals and teams to effectively prioritise and deliver
high quality care post-ePA. Our findings support this
and provide useful insights on how ePA has influenced
pharmacists’ work processes on an acute admissions and
a medicine-for–the-elderly ward. We suggest updating
guidance on specific work processes (e.g. using ePA to
document queries arising from clinical screening of in-
patient medications, recording medication history and
medicines reconciliation) to maximise the efficiency of
having a centralised system for written communication,
and supporting pharmacists to involve patients routinely
when reviewing their medications using a mobile com-
puting device on the ward. We also suggest actively en-
couraging staff to report any difficulties or workarounds
with ePA to the pharmacy ePA team to facilitate shared
learning and identity actions as required to address any
problems. Furthermore, we recommend increasing the
number of mobile computing devices available to ward
pharmacy staff, and a review of the location of computer
terminals on the wards to facilitate greater access to the
ePA system.
Future research
The perceived increase in medication errors is a concern
and we suggest future research to develop and evaluate
methods to monitor the extent to which ePA-related
and non-ePA errors are captured in routine practice. We
also suggest capturing types of remedial actions to facili-
tate organisational learning and greater shared learning
across the health sector. Finally, we suggest further re-
search should seek to map and better understand the
unintended consequences of ePA, particularly on how it
may enhance (or potentially generate more) work for
health professionals in order to improve patient safety.
Any system design should also consider how users may
change in the short, medium, and long term as appropri-
ate. For example, pharmacists who have never worked
with paper charts - and consequently never experienced
how patient contact naturally arises from bedside
screening of paper charts [7] or how regular patient con-
tact provides greater opportunities for a patient to con-
tribute to increased medication safety [27] may benefit
from a clear patient-focused practice model.
Conclusion
This study provides quantitative and qualitative insights
into the effects of implementing ePA on ward pharma-
cists’ activities. Some tasks took longer while others re-
duced, and our results suggest that pharmacists may
spend less time with patients with ePA. Pharmacists
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valued a number of safety features associated with ePA
but also perceived an overall increase in medication risk.
Pharmacy staff demonstrated a degree of resilience to
ensure ‘business as usual’ by enhancing and adapting
their role.
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